Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
The average-risk age threshold for colorectal cancer screening: should it be lowered?.

Digestive diseases and sciences

Imperiale TF.
PMID: 21360278
Dig Dis Sci. 2011 May;56(5):1249-51. doi: 10.1007/s10620-011-1650-x.

No abstract available.

Cite
Imperiale TF. The average-risk age threshold for colorectal cancer screening: should it be lowered?. Dig Dis Sci. 2011;56(5):1249-51doi: 10.1007/s10620-011-1650-x.
Imperiale, T. F. (2011). The average-risk age threshold for colorectal cancer screening: should it be lowered?. Digestive diseases and sciences, 56(5), 1249-51. https://doi.org/10.1007/s10620-011-1650-x
Imperiale, Thomas F. "The average-risk age threshold for colorectal cancer screening: should it be lowered?." Digestive diseases and sciences vol. 56,5 (2011): 1249-51. doi: https://doi.org/10.1007/s10620-011-1650-x
Imperiale TF. The average-risk age threshold for colorectal cancer screening: should it be lowered?. Dig Dis Sci. 2011 May;56(5):1249-51. doi: 10.1007/s10620-011-1650-x. PMID: 21360278.
Copy Download .nbib Format: NLM
Cancer screening: when is the juice worth the squeeze?.

Journal of the National Comprehensive Cancer Network : JNCCN

Tempero M.
PMID: 25313175
J Natl Compr Canc Netw. 2014 Oct;12(10):1359. doi: 10.6004/jnccn.2014.0133.

No abstract available.

Cite
Tempero M. Cancer screening: when is the juice worth the squeeze?. J Natl Compr Canc Netw. 2014;12(10):1359doi: 10.6004/jnccn.2014.0133.
Tempero, M. (2014). Cancer screening: when is the juice worth the squeeze?. Journal of the National Comprehensive Cancer Network : JNCCN, 12(10), 1359. https://doi.org/10.6004/jnccn.2014.0133
Tempero, Margaret. "Cancer screening: when is the juice worth the squeeze?." Journal of the National Comprehensive Cancer Network : JNCCN vol. 12,10 (2014): 1359. doi: https://doi.org/10.6004/jnccn.2014.0133
Tempero M. Cancer screening: when is the juice worth the squeeze?. J Natl Compr Canc Netw. 2014 Oct;12(10):1359. doi: 10.6004/jnccn.2014.0133. PMID: 25313175.
Copy Download .nbib Format: NLM
Budget Impact Analysis of Cancer Screening: A Methodological Review.

Applied health economics and health policy

Jahn B, Todorovic J, Bundo M, Sroczynski G, Conrads-Frank A, Rochau U, Endel G, Wilbacher I, Malbaski N, Popper N, Chhatwal J, Greenberg D, Mauskopf J, Siebert U.
PMID: 31016686
Appl Health Econ Health Policy. 2019 Aug;17(4):493-511. doi: 10.1007/s40258-019-00475-6.

BACKGROUND: Budget impact analyses (BIAs) describe changes in intervention- and disease-related costs of new technologies. Evidence on the quality of BIAs for cancer screening is lacking.OBJECTIVES: We systematically reviewed the literature and methods to assess how closely BIA guidelines...

Cite
Jahn B, Todorovic J, Bundo M, et al. Budget Impact Analysis of Cancer Screening: A Methodological Review. Appl Health Econ Health Policy. 2019;17(4):493-511doi: 10.1007/s40258-019-00475-6.
Jahn, B., Todorovic, J., Bundo, M., Sroczynski, G., Conrads-Frank, A., Rochau, U., Endel, G., Wilbacher, I., Malbaski, N., Popper, N., Chhatwal, J., Greenberg, D., Mauskopf, J., & Siebert, U. (2019). Budget Impact Analysis of Cancer Screening: A Methodological Review. Applied health economics and health policy, 17(4), 493-511. https://doi.org/10.1007/s40258-019-00475-6
Jahn, Beate, et al. "Budget Impact Analysis of Cancer Screening: A Methodological Review." Applied health economics and health policy vol. 17,4 (2019): 493-511. doi: https://doi.org/10.1007/s40258-019-00475-6
Jahn B, Todorovic J, Bundo M, Sroczynski G, Conrads-Frank A, Rochau U, Endel G, Wilbacher I, Malbaski N, Popper N, Chhatwal J, Greenberg D, Mauskopf J, Siebert U. Budget Impact Analysis of Cancer Screening: A Methodological Review. Appl Health Econ Health Policy. 2019 Aug;17(4):493-511. doi: 10.1007/s40258-019-00475-6. PMID: 31016686.
Copy Download .nbib Format: NLM
Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs.

Preventing chronic disease

Hoover S, Subramanian S, Tangka F.
PMID: 31050637
Prev Chronic Dis. 2019 May 02;16:E54. doi: 10.5888/pcd16.180336.

INTRODUCTION: We developed a web-based cost assessment tool (CAT) to collect cost data as an improvement from a desktop instrument to perform economic evaluations of the Centers for Disease Control and Prevention's (CDC's) Colorectal Cancer Control Program (CRCCP) grantees....

Cite
Hoover S, Subramanian S, Tangka F. Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs. Prev Chronic Dis. 2019;16:E54doi: 10.5888/pcd16.180336.
Hoover, S., Subramanian, S., & Tangka, F. (2019). Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs. Preventing chronic disease, 16E54. https://doi.org/10.5888/pcd16.180336
Hoover, Sonja, et al. "Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs." Preventing chronic disease vol. 16 (2019): E54. doi: https://doi.org/10.5888/pcd16.180336
Hoover S, Subramanian S, Tangka F. Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs. Prev Chronic Dis. 2019 May 02;16:E54. doi: 10.5888/pcd16.180336. PMID: 31050637; PMCID: PMC6513486.
Copy Download .nbib Format: NLM
Cancer Screening: Finding the Path Forward.

The Medical clinics of North America

Ende J.
PMID: 33099457
Med Clin North Am. 2020 Nov;104(6):xiii-xiv. doi: 10.1016/j.mcna.2020.08.011. Epub 2020 Sep 16.

No abstract available.

Cite
Ende J. Cancer Screening: Finding the Path Forward. Med Clin North Am. 2020;104(6):xiii-xivdoi: 10.1016/j.mcna.2020.08.011.
Ende, J. (2020). Cancer Screening: Finding the Path Forward. The Medical clinics of North America, 104(6), xiii-xiv. https://doi.org/10.1016/j.mcna.2020.08.011
Ende, Jack. "Cancer Screening: Finding the Path Forward." The Medical clinics of North America vol. 104,6 (2020): xiii-xiv. doi: https://doi.org/10.1016/j.mcna.2020.08.011
Ende J. Cancer Screening: Finding the Path Forward. Med Clin North Am. 2020 Nov;104(6):xiii-xiv. doi: 10.1016/j.mcna.2020.08.011. Epub 2020 Sep 16. PMID: 33099457.
Copy Download .nbib Format: NLM
Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine.

PLoS medicine

Shapiro SD.
PMID: 28170392
PLoS Med. 2017 Feb 07;14(2):e1002226. doi: 10.1371/journal.pmed.1002226. eCollection 2017 Feb.

In a Perspective on the Research Article by ten Haaf and colleagues, Steven Shapiro discusses the challenges of identifying screening strategies that maximize the number of cancers diagnosed, while minimizing the harms of overdiagnosis and maintaining cost-effectiveness.

Cite
Shapiro SD. Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine. PLoS Med. 2017;14(2):e1002226doi: 10.1371/journal.pmed.1002226.
Shapiro, S. D. (2017). Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine. PLoS medicine, 14(2), e1002226. https://doi.org/10.1371/journal.pmed.1002226
Shapiro, Steven D. "Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine." PLoS medicine vol. 14,2 (2017): e1002226. doi: https://doi.org/10.1371/journal.pmed.1002226
Shapiro SD. Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine. PLoS Med. 2017 Feb 07;14(2):e1002226. doi: 10.1371/journal.pmed.1002226. eCollection 2017 Feb. PMID: 28170392; PMCID: PMC5295661.
Copy Download .nbib Format: NLM
Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?.

Journal of global oncology

Shah SC, Kayamba V, Peek RM, Heimburger D.
PMID: 30908147
J Glob Oncol. 2019 Mar;5:1-8. doi: 10.1200/JGO.18.00200.

The rising prevalence of noncommunicable diseases globally, with a strikingly disproportionate increase in prevalence and related mortality in low- and middle-income countries (LMICs), is a major threat to sustainable development. The epidemiologic trend of cancers in LMICs is of...

Cite
Shah SC, Kayamba V, Peek RM, et al. Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?. J Glob Oncol. 2019;5:1-8doi: 10.1200/JGO.18.00200.
Shah, S. C., Kayamba, V., Peek, R. M., & Heimburger, D. (2019). Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?. Journal of global oncology, 51-8. https://doi.org/10.1200/JGO.18.00200
Shah, Shailja C, et al. "Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?." Journal of global oncology vol. 5 (2019): 1-8. doi: https://doi.org/10.1200/JGO.18.00200
Shah SC, Kayamba V, Peek RM, Heimburger D. Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?. J Glob Oncol. 2019 Mar;5:1-8. doi: 10.1200/JGO.18.00200. PMID: 30908147; PMCID: PMC6452918.
Copy Download .nbib Format: NLM
A value framework for cancer screening: advice for high-value care from the American College of Physicians.

Annals of internal medicine

Harris RP, Wilt TJ, Qaseem A.
PMID: 25984846
Ann Intern Med. 2015 May 19;162(10):712-7. doi: 10.7326/M14-2327.

Experts, professional societies, and consumer groups often recommend different strategies for cancer screening. These strategies vary in the intensity of their search for asymptomatic lesions and in their value. This article outlines a framework for thinking about the value...

Cite
Harris RP, Wilt TJ, Qaseem A. A value framework for cancer screening: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162(10):712-7doi: 10.7326/M14-2327.
Harris, R. P., Wilt, T. J., Qaseem, A. (2015). A value framework for cancer screening: advice for high-value care from the American College of Physicians. Annals of internal medicine, 162(10), 712-7. https://doi.org/10.7326/M14-2327
Harris, Russell P, et al. "A value framework for cancer screening: advice for high-value care from the American College of Physicians." Annals of internal medicine vol. 162,10 (2015): 712-7. doi: https://doi.org/10.7326/M14-2327
Harris RP, Wilt TJ, Qaseem A. A value framework for cancer screening: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015 May 19;162(10):712-7. doi: 10.7326/M14-2327. PMID: 25984846.
Copy Download .nbib Format: NLM
Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies.

Journal of global oncology

Autier P, Sullivan R.
PMID: 30715958
J Glob Oncol. 2019 Feb;5:1-5. doi: 10.1200/JGO.18.00235.

No abstract available.

Cite
Autier P, Sullivan R. Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies. J Glob Oncol. 2019;5:1-5doi: 10.1200/JGO.18.00235.
Autier, P., & Sullivan, R. (2019). Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies. Journal of global oncology, 51-5. https://doi.org/10.1200/JGO.18.00235
Autier, Philippe, and Sullivan, Richard. "Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies." Journal of global oncology vol. 5 (2019): 1-5. doi: https://doi.org/10.1200/JGO.18.00235
Autier P, Sullivan R. Population Screening for Cancer in High-Income Settings: Lessons for Low- and Middle-Income Economies. J Glob Oncol. 2019 Feb;5:1-5. doi: 10.1200/JGO.18.00235. PMID: 30715958; PMCID: PMC6426516.
Copy Download .nbib Format: NLM
Economic evaluation of colorectal cancer (CRC) screening.

Best practice & research. Clinical gastroenterology

Cruzado J, Sánchez FI, Abellán JM, Pérez-Riquelme F, Carballo F.
PMID: 24182607
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):867-80. doi: 10.1016/j.bpg.2013.09.004. Epub 2013 Sep 27.

Because of its incidence and mortality colorectal cancer represents a serious public health issue in industrial countries. In order to reduce its social impact a number of screening strategies have been implemented, which allow an early diagnosis and treatment....

Cite
Cruzado J, Sánchez FI, Abellán JM, et al. Economic evaluation of colorectal cancer (CRC) screening. Best Pract Res Clin Gastroenterol. 2013;27(6):867-80doi: 10.1016/j.bpg.2013.09.004.
Cruzado, J., Sánchez, F. I., Abellán, J. M., Pérez-Riquelme, F., & Carballo, F. (2013). Economic evaluation of colorectal cancer (CRC) screening. Best practice & research. Clinical gastroenterology, 27(6), 867-80. https://doi.org/10.1016/j.bpg.2013.09.004
Cruzado, José, et al. "Economic evaluation of colorectal cancer (CRC) screening." Best practice & research. Clinical gastroenterology vol. 27,6 (2013): 867-80. doi: https://doi.org/10.1016/j.bpg.2013.09.004
Cruzado J, Sánchez FI, Abellán JM, Pérez-Riquelme F, Carballo F. Economic evaluation of colorectal cancer (CRC) screening. Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):867-80. doi: 10.1016/j.bpg.2013.09.004. Epub 2013 Sep 27. PMID: 24182607.
Copy Download .nbib Format: NLM
On cancer detection. Early diagnosis could save lives.

The Health service journal

Field S.
PMID: 21189506
Health Serv J. 2010 Sep 30;120(6226):12-3.

No abstract available.

Cite
Field S. On cancer detection. Early diagnosis could save lives. Health Serv J. 2010;120(6226):12-3
Field, S. (2010). On cancer detection. Early diagnosis could save lives. The Health service journal, 120(6226), 12-3.
Field, Steve. "On cancer detection. Early diagnosis could save lives." The Health service journal vol. 120,6226 (2010): 12-3.
Field S. On cancer detection. Early diagnosis could save lives. Health Serv J. 2010 Sep 30;120(6226):12-3. PMID: 21189506.
Copy Download .nbib Format: NLM
Guidelines on cervical and breast cancer screening in Greece.

Lancet (London, England)

Vrachnis N, Vlachadis N.
PMID: 25752175
Lancet. 2015 Feb 28;385(9970):772. doi: 10.1016/S0140-6736(15)60434-2.

No abstract available.

Cite
Vrachnis N, Vlachadis N. Guidelines on cervical and breast cancer screening in Greece. Lancet. 2015;385(9970):772doi: 10.1016/S0140-6736(15)60434-2.
Vrachnis, N., & Vlachadis, N. (2015). Guidelines on cervical and breast cancer screening in Greece. Lancet (London, England), 385(9970), 772. https://doi.org/10.1016/S0140-6736(15)60434-2
Vrachnis, Nikolaos, and Vlachadis, Nikolaos. "Guidelines on cervical and breast cancer screening in Greece." Lancet (London, England) vol. 385,9970 (2015): 772. doi: https://doi.org/10.1016/S0140-6736(15)60434-2
Vrachnis N, Vlachadis N. Guidelines on cervical and breast cancer screening in Greece. Lancet. 2015 Feb 28;385(9970):772. doi: 10.1016/S0140-6736(15)60434-2. PMID: 25752175.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries